Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 Insertion

NCT05419700

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Universitario Reina Sofia Córdoba, Andalusia, Spain
  • Hospital Universitario Virgen de la Victoria Málaga, Andalusia, Spain
  • Hospital Universitario Virgen del Rocio Seville, Andalusia, Spain
  • ICO Badalona. Hospital Universitario Germans Trias i Pujol Badalona, Catalonia, Spain
View all 15 locations
View Trial Details
Completed

RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

NCT05933044

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • BC Cancer Vancouver, British Columbia, Canada
  • Queen Elizabeth (QE) II Health Sciences Centre Halifax, Nova Scotia, Canada
  • The Ottawa Hospital Ottawa, Ontario, Canada
View Trial Details
Completed

The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy

NCT03559647

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hämato-Onkologische Schwerpunktpraxis am Klinikum Aschaffenburg Aschaffenburg, Germany
  • Studienzentrum Aschaffenburg Aschaffenburg, Germany
  • Zentralklinikum Augsburg Augsburg, Germany
  • Dres. Helmut Tanzer Joachim Hornberger und Johannes Kern Bad Reichenhall, Germany
View all 94 locations
View Trial Details
Completed

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

NCT02658890

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Local Institution - 0028 Tucson, Arizona, United States
  • Local Institution - 0026 La Jolla, California, United States
  • Local Institution - 0035 Tampa, Florida, United States
  • Local Institution - 0005 Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Completed

Phase II Trial of Continuation Therapy in Advanced NSCLC

NCT03083808

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospital Clinics Iowa City, Iowa, United States
  • University of Minnesota Medcical Center Minneapolis, Minnesota, United States
View Trial Details

Related conditions